Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
07 août 2024 07h00 HE
|
Fractyl Health, Inc.
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates
07 août 2024 07h00 HE
|
Madrigal Pharmaceuticals, Inc.
Second-quarter 2024 net sales of $14.6 million Rezdiffra™ (resmetirom) coverage in place for more than 50 percent of commercial lives; less than 5 percent of Rezdiffra-covered lives require...
Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer
07 août 2024 02h00 HE
|
Cellectis Inc.
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
06 août 2024 16h05 HE
|
Vaxcyte, Inc.
-- VAX-31 Adult Phase 1/2 Study Topline Safety, Tolerability and Immunogenicity Data Expected in September 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Results, Vaxcyte to Advance VAX-24 or...
Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
06 août 2024 16h02 HE
|
Olema Oncology
Presented promising interim clinical results from the ongoing study of palazestrant in combination with ribociclib at the 2024 ESMO Breast Cancer Congress. Updated results expected to be presented at...
Global Water Center Launches Carbon Credit Program to Help Fund Sustainable Rural Water Systems
06 août 2024 15h25 HE
|
Global Water Center
Global Water Center started a Carbon Credit Program to make rural water systems financially sustainable.
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
06 août 2024 08h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
06 août 2024 02h30 HE
|
Abivax
Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC) surpassed the...
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
05 août 2024 16h01 HE
|
Recursion Pharmaceuticals
Salt Lake City, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech
05 août 2024 10h16 HE
|
NodThera
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech Philadelphia, PA, August 5, 2024 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic...